307 related articles for article (PubMed ID: 31900917)
21. Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3'-diindolylmethane in an enzalutamide-resistant prostate cancer cell line.
Tsao CW; Li JS; Lin YW; Wu ST; Cha TL; Liu CY
Sci Rep; 2021 Jan; 11(1):1239. PubMed ID: 33441906
[TBL] [Abstract][Full Text] [Related]
22. Nuclear receptor NURR1 functions to promote stemness and epithelial-mesenchymal transition in prostate cancer via its targeting of Wnt/β-catenin signaling pathway.
Zhang X; Li H; Wang Y; Zhao H; Wang Z; Chan FL
Cell Death Dis; 2024 Mar; 15(3):234. PubMed ID: 38531859
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.
Abd Wahab NA; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32131560
[TBL] [Abstract][Full Text] [Related]
24. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.
Liu S; Wang Q; Liu Y; Xia ZY
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580
[TBL] [Abstract][Full Text] [Related]
25. Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration.
Yu X; Wang Y; Jiang M; Bierie B; Roy-Burman P; Shen MM; Taketo MM; Wills M; Matusik RJ
Prostate; 2009 Feb; 69(3):249-62. PubMed ID: 18991257
[TBL] [Abstract][Full Text] [Related]
26. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
27. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
28. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway.
Li R; Quan Y; Xia W
Exp Cell Res; 2018 Mar; 364(2):143-151. PubMed ID: 29421536
[TBL] [Abstract][Full Text] [Related]
29. Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells.
Lee E; Ha S; Logan SK
PLoS One; 2015; 10(10):e0141589. PubMed ID: 26509262
[TBL] [Abstract][Full Text] [Related]
30. Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling.
El-Sayed IY; Daher A; Destouches D; Firlej V; Kostallari E; Maillé P; Huet E; Haidar-Ahmad N; Jenster G; de la Taille A; Abou Merhi R; Terry S; Vacherot F
Cancer Lett; 2017 Dec; 410():100-111. PubMed ID: 28935391
[TBL] [Abstract][Full Text] [Related]
31. Profiling Prostate Cancer Therapeutic Resistance.
Wade CA; Kyprianou N
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562686
[TBL] [Abstract][Full Text] [Related]
32. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
33. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
34. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
Stakheev D; Taborska P; Strizova Z; Podrazil M; Bartunkova J; Smrz D
Sci Rep; 2019 Mar; 9(1):4761. PubMed ID: 30886380
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells.
Horton C; Liu Y; Wang J; Green J; Tsyporin J; Chen B; Wang ZA
Stem Cell Reports; 2023 Jun; 18(6):1355-1370. PubMed ID: 37172587
[TBL] [Abstract][Full Text] [Related]
36. The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer.
Kazmi I; Altamimi ASA; Afzal M; Majami AA; AlGhamdi AS; Alkinani KB; Abbasi FA; Almalki WH; Alzera SI; Kukreti N; Fuloria NK; Sekar M; Abida
Pathol Res Pract; 2024 Feb; 254():155134. PubMed ID: 38277746
[TBL] [Abstract][Full Text] [Related]
37. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
38. WNT signalling in prostate cancer.
Murillo-Garzón V; Kypta R
Nat Rev Urol; 2017 Nov; 14(11):683-696. PubMed ID: 28895566
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.
Martinez SR; Elix CC; Ochoa PT; Sanchez-Hernandez ES; Alkashgari HR; Ortiz-Hernandez GL; Zhang L; Casiano CA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108293
[TBL] [Abstract][Full Text] [Related]
40. Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts.
Hong JH; Lee G; Choi HY
Korean J Urol; 2015 Sep; 56(9):656-65. PubMed ID: 26366279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]